Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Cash from Financing Activities: 2019-2024

Historic Cash from Financing Activities for Agilon Health (AGL) over the last 6 years, with FY2024 value amounting to -$2.6 million.

  • Agilon Health's Cash from Financing Activities rose 8321.48% to -$236000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.1 million, marking a year-over-year decrease of 5674.33%. This contributed to the annual value of -$2.6 million for FY2024, which is 9866.26% up from last year.
  • Latest data reveals that Agilon Health reported Cash from Financing Activities of -$2.6 million as of FY2024, which was up 9866.26% from -$193.1 million recorded in FY2023.
  • In the past 5 years, Agilon Health's Cash from Financing Activities ranged from a high of $1.2 billion in FY2021 and a low of -$193.1 million during FY2023
  • Over the past 5 years, Agilon Health's median Cash from Financing Activities value was $24.6 million (recorded in 2020), while the average stood at $202.3 million.
  • In the last 5 years, Agilon Health's Cash from Financing Activities surged by 458863.98% in 2021 and then plummeted by 78838.39% in 2023.
  • Agilon Health's Cash from Financing Activities (Annual) stood at $24.6 million in 2020, then surged by 4588.64% to $1.2 billion in 2021, then crashed by 97.57% to $28.1 million in 2022, then plummeted by 788.38% to -$193.1 million in 2023, then skyrocketed by 98.66% to -$2.6 million in 2024.
  • Its last three reported values are -$2.6 million in FY2024, -$193.1 million for FY2023, and $28.1 million during FY2022.